Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Ingenus Pharmaceuticals NJ, LLC.
FDA Inspection
•Ingenus Pharmaceuticals NJ, LLC.•July 17, 2026

Ingenus Pharmaceuticals NJ, LLC. – FDA Inspection, Jul 17, 2026

Record Details

This FDA Inspection record concerns Ingenus Pharmaceuticals NJ, LLC., with an inspection on July 17, 2026, issued by the New Jersey District Office, covering medical devices & rad health.

Company
Ingenus Pharmaceuticals NJ, LLC.
Inspection Date
July 17, 2026
Product Type
Medical Devices & Rad Health
Office
New Jersey District Office
People
  • Frank J. Marciniak (Issuing Officer)
  • Tanya R. Syffrard (Issuing Officer)
View Company Profile

ID · f3be65ed-a6c2-475a-8b10-9e041684c676

Inspection Facts

Inspection number
1326668
FDA center
Medical Devices & Rad Health
Project area
Compliance: Devices
Outcome
Form 483 issued

FDA Citations

7
  1. 21 CFR 211.67(b)Written procedures not established/followed
  2. ISO 13485:2016 Clause 4.1.2Risk-based approach not applied to QMS processes
  3. ISO 13485:2016 Clause 4.1.5External party controls do not include written quality agreements
  4. ISO 13485:2016 Clause 7.3.1Design and development procedures not documented
  5. ISO 13485:2016 Clause 7.3.3Design and development inputs do not include all requirements
  6. ISO 13485:2016 Clause 7.3.5Records of design and development reviews not maintained
  7. ISO 13485:2016 Clause 7.3.6Design and development verification not performed

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Ingenus Pharmaceuticals NJ, LLC.

12
DateClassificationOfficeProject area
January 9, 2026Not classifiedNew Jersey District Office
February 18, 2022NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
January 24, 2019NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
December 14, 2017VAINew Jersey District OfficeGeneric Drug Evaluation
September 27, 2017VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 12 other inspections on the company page
Other documents for Ingenus Pharmaceuticals NJ, LLC.
  • FDA Inspection 1302128 - 2026-01-09
  • FDA Inspection 1164226 - 2022-02-18
  • FDA Inspection 1079060 - 2019-01-24
  • FDA Inspection 1035002 - 2017-12-14
  • FDA Inspection 1026727 - 2017-09-27

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Ingenus Pharmaceuticals NJ, LLC.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.